NRDS vs QNST

NRDS exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and a pristine balance sheet (Debt/Equity 0.04). However, the stock is currently trading at a premium to both its Graham Number ($8.7) and Intrinsic Value ($4.48). While revenue growth remains robust at 22.6%, a severe collapse in earnings growth (-62.5%) and consistent earnings misses create a significant fundamental disconnect. The combination of bearish insider activity and a poor earnings track record offsets the strong liquidity and low valuation multiples.

QNST demonstrates strong financial health with a Piotroski F-Score of 7/9 and an exceptionally low Debt/Equity ratio of 0.03. While the current price of $12.75 trades at a premium to the Graham Number ($11.15) and the growth-based Intrinsic Value ($7.49), the company maintains a low Forward P/E of 7.98 and a strong ROE of 24.05%. The primary conflict lies between impressive earnings consistency (3/4 recent beats) and stagnant top-line revenue growth of only 1.90%. Consequently, the stock presents as a fundamentally sound value play that currently lacks a technical or growth-driven catalyst for a breakout.